Summary
Growth hormone treatment produced somatotrophic diabetes, with hyperglycaemia, polyuria, glycosuria and elevation in serum non-esterified fatty acids (NEFA) in dogs. Early in this diabetes, fasting serum immunoreactive insulin (IRI) rose 20-fold, the insulin/glucose (I/G) ratio rose 10-fold and in response to glucose infusion, the rise in IRI was twice the normal. In the latter half of the continued growth hormone treatment, the intensity of the diabetes increased, serum IRI declined to the normal level and the I/G ratio became subnormal. Late in the treatment, following glucose infusion, there was no change in serum IRI, no fall in NEFA and further depression of glucose tolerance. In metasomatotrophic diabetes, in which hyperglycaemia, glycosuria and high NEFA level persisted, fasting serum IRI was normal during several months, then became subnormal and the I/G ratio was diminished further. Following glucose IV there was no change in serum IRI, no fall in NEFA and low glucose tolerance. The normally-occurring rises in serum IRI following arginine and glucagon IV and after the ingestion of a meal were absent. These permanently diabetic dogs were responsive to insulin IV. The insulin content of the pancreas was reduced to about 1.2% of the normal after 14 months of this diabetes. From the sequence of change it is concluded that growth hormone induced metasomatotrophic diabetes by causing excessive secretion of insulin under basal and stimulative conditions, leading to permanent loss of function of the beta cells of the pancreatic islets, to such an extent that basal insulin secretion was low and the ability to secrete extra insulin in response to stimuli was lost.
Article PDF
Similar content being viewed by others
References
Campbell J, Davidson I W F, Lei H P (1950) The production of permanent diabetes by highly purified growth hormone. Endocrinology 46: 588–590
Campbell J, Chaikof L, Davidson IWF (1954) Metahypophyseal diabetes produced by growth hormone. Endocrinology 54: 48–58
Engerman R L, Davis M D, Bloodworth J M B Jr (1971) Retinopathy in experimental diabetes: its relevance to diabetic retinopathy in man. In: Diabetes. Excerpta Medica Int Congr Series 231: 261–267
Houssay B A, Rodriguez R R, Cardeza A F (1953) Accion diabetogena de la hormona de crecimento de la hipofisis. Rev Soc Argent Biol 29: 33–41
Young F G (1937) Permanent diabetes produced by pituitary (anterior lobe) injections. Lancet II: 372–374
Loubatières A (1939) Recherches sur la diabète surcé permanent consécutif aux injections d'extrait de lobe antérieur d'hypophyse chez le chien normal. C R Acad Sci [D] (Paris) 208: 1933–1935
Dohan F C, Lukens F D W (1939) Persistent diabetes following the injection of anterior pituitary extract. Am J Physiol 125: 188–195
Houssay B A, Foglia V G (1944) La diabetes metahipofisaria. Rev Soc Argent Biol 20: 247–259
Young F G (1949) The relationship of the anterior pituitary gland to diabetes mellitus. Acta Med Scand 135: 275–288
Campbell J (1955) Diabetogenic actions of growth hormone. In: Smith R W Jr, Gaebler O H, Long C N H (eds) The hypophyseal growth hormone, nature and actions. McGraw-Hill, New York, p 270–285
Richardson K C, Young F G (1938) Histology of diabetes induced in dogs by injection of anterior-pituitary extracts. Lancet I: 1098–1101
Campbell J, Pierluissi J, Green G R (1978) Somatotrophic diabetes: insulin release responses to arginine and glucagon in dogs. Diabetologia 15: 205–212
Okuda J, Okuda G (1969) A rapid polargraphic microdetermination of glucose with glucose oxidase. Clin Chim Acta 23: 365–367
Itaya K, Ui M (1965) Colorimetric determination of free fatty acids in biological fluids. J Lipid Res 6: 16–20
Hales C N, Randle P J (1963) Immunoassay of insulin with insulin-antibody precipitate. Biochem J 88: 137–146
Dumm R M, Shipley R A (1946) The simple estimation of blood ketones in diabetic acidosis. J Lab Clin Med 31: 1162–1163
Davoreen P R (1962) The isolation of insulin from a single cat pancreas. Biochim Biophys Acta 63: 150–153
Lillie R D (1965) Histological technique and practical histochemistry, 3 ed. McGraw-Hill, New York
Campbell J, Rastogi K S (1968) Elevation in serum insulin, albumin, and FFA with gains in liver lipid and protein induced by glucocorticoid treatment in dogs. Can J Physiol Pharmacol 46: 421–429
Campbell J, Rastogi K S (1966) Growth hormone-induced diabetes and high levels of serum insulin in dogs. Diabetes 15: 30–43
Sirek A, Vranic M, Sirek O V (1977) Effect of a single somatotropin (STH) injection on plasma insulin and glucagon levels in the dog. Proc Int Union Physiol Sci 12: 701
Pierluissi J (1979) Insulin and glucagon levels in young dogs treated with growth hormone. In: Pierluissi J (ed) Endocrine pancreas and diabetes. Excerpta Medica Int Congr Series 459: 220–229
Campbell J, Rastogi K S (1969) Actions of growth hormone: enhancement of insulin utilization with inhibition of insulin effect on blood glucose in dogs. Metabolism 18: 930–944
Muggeo M, Bar R S, Roth J, Kahn C R, Gorden P (1979) The insulin resistance of acromegaly: evidence for two alterations in the insulin receptor on circulating monocytes. J Clin Endocrinol Metab 48: 17–25
Pek S, Tai T-Y, Crowther R, Fajans S S (1976) Glucagon release precedes insulin release in response to common secretagogues. Diabetes 25: 764–770
Tai T-Y, Pek S (1979) Direct stimulation by growth hormone of glucagon and insulin release from isolated rat pancreas. Endocrinology 99: 669–677
Pierluissi J, Oliviera A, de Maksimenko A, Espinosa I (1977) Effect of growth hormone on insulin secretion in young dogs. Proc Int Union Physiol Sci 13: 598
Campbell J, Rastogi K S (1966) Augmented insulin secretion due to growth hormone. Stimulating effects of glucose and food in dogs. Diabetes 15: 749–758
Kostyo J L: Search for the active site of growth hormone. In: James V H T (ed) Endocrinology, vol 2. Excerpta Medica Int Congr Series 403: 186–190
Lewis U J, Singh R N P, Vanderlaan W P, Tutwiler G F (1977) Enhancement of the hyperglycemic activity of human growth hormone by enzymic modification. Endocrinology 101: 1587–1603
Volk B W, Lazarus S S (1962) Ultramicroscopy of dog islets in growth hormone diabetes. Diabetes 11: 420–435
Malaisse W J, Malaisse-Lagae F, King S, Wright F H (1968) Effect of growth hormone on insulin secretion. Am J Physiol 215: 423–428
Martin J H, Åkerblom H K, Garay G (1968) Insulin secretion in rats with elevated levels of circulating growth hormone due to MtT-W15 tumor. Diabetes 17: 661–667
Bencosme S A, Tsutsumi V, Martin J M, Åkerblom H K (1971) Ultrastructural changes in B cells of pancreatic islets from rats with elevated levels of circulating growth hormone secreted by MtT-W15 tumor. Diabetes 20: 15–26
Pierluissi J, Norwich K H, Green G R, Campbell J (1978) Insulin kinetics in metasomatotrophic diabetes. Metabolism 27: 61–70
Marks H P, Young F G (1939) Observations on the metabolism of dogs made permanently diabetic by treatment with anterior pituitary extract. J Endocrinol 1: 470–510
Randle P J (1977) Protein phosphorylation and dephosphorylation and insulin action. In: Bajaj J S (ed) Diabetes. Excerpta Medica Int Congr Series 413: 169–179
Luft R, Cerasi E, Hausberger C A (1967) Studies on the pathogenesis of diabetes in acromegaly. Acta Endocrinol (Kbh) 56: 593–607
Fineberg S E, Merimee T J, Rabinowitz D, Edgar P J (1970) Insulin secretion in acromegaly. J Clin Endocrinol 30: 288–292
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pierluissi, J., Campbell, J. Metasomatotrophic diabetes and its induction: Basal insulin secretion and insulin release responses to glucose, glucagon, arginine and meals. Diabetologia 18, 223–228 (1980). https://doi.org/10.1007/BF00251920
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00251920